The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Cytokine release syndrome (CRS) and neurotoxicity (NT) after CD19-specific chimeric antigen receptor- (CAR-) modified T cells.
 
Cameron John Turtle
Consulting or Advisory Role - Adaptive Biotechnologies; Bluebird Bio; Celgene; Juno Therapeutics; Precision Biosciences; Seagen
Research Funding - Juno Therapeutics
Patents, Royalties, Other Intellectual Property - Two patents licensed or pending
 
Kevin Anthony Hay
No Relationships to Disclose
 
Juliane Gust
No Relationships to Disclose
 
Laila-Aicha Hanafi
No Relationships to Disclose
 
Daniel Li
Employment - Juno Therapeutics
Stock and Other Ownership Interests - Juno Therapeutics
Patents, Royalties, Other Intellectual Property - Juno Therapeutics
 
W. Conrad Liles
Patents, Royalties, Other Intellectual Property - University of Washington
 
Mark Wurfel
Patents, Royalties, Other Intellectual Property - University of Washington
 
Susanna Harju-Baker
No Relationships to Disclose
 
David Myerson
No Relationships to Disclose
 
Luis Gonzalez-Cuyar
No Relationships to Disclose
 
Cecilia CS Yeung
Research Funding - Gilead Sciences
 
Stanley R. Riddell
Stock and Other Ownership Interests - Juno Therapeutics
Research Funding - Juno Therapeutics; Juno Therapeutics (Inst)
Patents, Royalties, Other Intellectual Property - Juno Therapeutics
 
David G. Maloney
Consulting or Advisory Role - Bristol-Myers Squibb; Celgene; Gilead Sciences; Immunogen; Roche; Seagen
Research Funding - Juno Therapeutics
Patents, Royalties, Other Intellectual Property - Two patents pending.